← Back to Search

Screening Tools for Anxiety and Depression in Epilepsy

N/A

Waitlist Available

Led By Heidi M. Munger Clary, MD, MPH

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 1

Awards & highlights

No Placebo-Only Group

Summary

This trial compares how well patients complete anxiety & depression assessments when using different methods, to see if the completion rate varies.

Who is the study for?

This trial is for adults with epilepsy who have a clinic visit scheduled at least 7 days in advance. There are no specific exclusions, meaning it's open to anyone meeting the inclusion criteria.

What is being tested?

The study is testing how well patients complete anxiety and depression questionnaires using different methods: REDCap versus Electronic Health Record (EHR) systems. It aims to see if one method leads to better completion rates.

What are the potential side effects?

Since this trial involves completing screening questionnaires rather than medication or medical procedures, there are no direct side effects associated with the interventions being studied.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Screening completion - Yes or No

Secondary study objectives

Accuracy of Kit Application Programming Interface (API)

Participant time from instrument delivery to completion

Research team time-instrument data entry

+1 more

Other study objectives

Clinic visit attendance: no-show

Clinic visit attendance:Visit canceled

Clinic visit attendance:Visit completed

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Active Control

Group I: Customized Email PromptActive Control1 Intervention

Subjects in this arm will be asked to complete standard care screening questionnaires on anxiety and depression, delivered by an email with a REDCap email survey link.

Group II: Text MessageActive Control1 Intervention

Subjects in this arm will be asked to complete standard care screening questionnaires on anxiety and depression, delivered by Twilio text message.

Group III: Generic Electronic Health Record (EHR) portal emailActive Control1 Intervention

Subjects in this arm will be prompted with customized EHR portal message after login to EHR portal.

Group IV: EHR Portal with No MessageActive Control1 Intervention

Subjects in this arm will not receive a reminder, but previsit questionnaires associated with a visit will be in their EHR portal.

Do I qualify?Apply below to find out